William Riehl
Program in Bioinformatics
Boston University
William Riehl graduated from Stanford University in 2000 with a BA in Human Biology, minoring in Computer Science. That same year, he went on to attend the Keck Graduate Institute of Applied life sciences, where he studied computational biology, bioengineering, and molecular biology, as applied toward the biotechnology and pharmaceutical industry. While at KGI, he worked with Greg Dewey to develop algorithms and tools for automated graph layout and data visualization, along with novel methods for protein structure alignment. His final capstone - participation in a team master's project - revolved around developing and applying algorithms to predict protein-protein interactions from amino acid sequence. Shortly after graduation from KGI in 2002, this project grew into a small startup, Zuyder Pharmaceuticals, led by David Galas and Jeff Van Ness, with the goal of predicting novel drug targets for metabolic bone disorders, such as osteoporosis. In 2005, William Riehl left Zuyder to pursue a Ph.D. in the Program in Bioinformatics at Boston University, where he joined Daniel Segre's group.